Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 46:508-515, doi:10.1016/j.jacc.2005.03.070 (Published online 14 July 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2005.03.070v1
46/3/508    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (113)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohkubo, T.
Right arrow Articles by Imai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohkubo, T.
Right arrow Articles by Imai, Y.

CLINICAL RESEARCH: HYPERTENSION

Prognosis of "Masked" Hypertension and "White-Coat" Hypertension Detected by 24-h Ambulatory Blood Pressure Monitoring

10-Year Follow-Up From the Ohasama Study

Takayoshi Ohkubo, MD, PhD*,§,||,*, Masahiro Kikuya, MD, PhD*,§, Hirohito Metoki, MD{dagger},§,||, Kei Asayama, MD{dagger},§,||, Taku Obara, MS{dagger},§, Junichiro Hashimoto, MD, PhD*,§,||, Kazuhito Totsune, MD, PhD{dagger},§,||, Haruhisa Hoshi, MD, PhD, Hiroshi Satoh, MD, PhD{ddagger},§,|| and Yutaka Imai, MD, PhD{dagger},§,||

* Department of Planning for Drug Development and Clinical Evaluation, Sendai
{dagger} Department of Clinical Pharmacology and Therapeutics, Sendai
{ddagger} Department of Environmental Health Science, Sendai
§ Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai
|| Tohoku University 21st Century COE Program "Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation," Sendai
Ohasama Hospital, Iwate, Japan

Manuscript received September 30, 2004; revised manuscript received February 23, 2005, accepted March 1, 2005.

* Reprint requests and correspondence: Dr. Takayoshi Ohkubo, Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Science, 1-1 Seiryo-cho, Aoba-ku, Sendai, 980-8574, Japan. (Email: tohkubo{at}mail.tains.tohoku.ac.jp).

OBJECTIVES: We sought to investigate the prognosis in subjects with "white-coat" hypertension (WCHT) and "masked" hypertension (MHT), in which blood pressure (BP) is lower in clinical measurements than during ambulatory monitoring.

BACKGROUND: The prognostic significance of WCHT remains controversial, and little is known about MHT.

METHODS: We obtained 24-h ambulatory BP and "casual" BP (i.e., obtained in clinical scenarios) values from 1,332 subjects (872 women, 460 men) ≥40 years old in a representative sample of the general population of a Japanese community. Survival and stroke morbidity were then followed up for a mean duration of 10 years.

RESULTS: Composite risk of cardiovascular mortality and stroke morbidity examined using a Cox proportional hazards regression model for subjects with WCHT (casual BP ≥140/90 mm Hg, daytime BP <135/85 mm Hg; relative hazards [RH])1.28; 95% confidence interval [CI] 0.76 to 2.14) was no different from risk for subjects with sustained normal BP (casual BP <140/90 mm Hg, daytime BP <135/85 mm Hg). However, risk was significantly higher for subjects with MHT (casual BP <140/90 mm Hg, daytime BP ≥135/85 mm Hg; RH 2.13; 95% CI 1.38 to 3.29) or sustained hypertension (casual BP ≥140/90 mm Hg, daytime BP ≥135/85 mm Hg; RH 2.26; 95% CI 1.49 to 3.41) than for subjects with sustained normal BP. Similar findings were observed for cardiovascular mortality and stroke morbidity among subgroups by gender, use of antihypertensive medication, and risk factor level (all p for heterogeneity >0.2).

CONCLUSIONS: Conventional BP measurements may not identify some individuals at high or low risk, but these people may be identifiable by the use of ambulatory BP.

Abbreviations and Acronyms
  BP = blood pressure
  CI = confidence interval
  MHT = masked hypertension
  RH = relative hazard
  SHT = sustained hypertension
  SNBP = sustained normal blood pressure
  TIA = transient ischemic attack
  WCHT = white-coat hypertension




This article has been cited by other articles:


Home page
Cleveland Clinic Journal of MedicineHome page
M. RAFEY
Beyond office sphygmomanometry: Ways to better assess blood pressure
Cleveland Clinic Journal of Medicine, November 1, 2009; 76(11): 657 - 662.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Obara, T. Ohkubo, and Y. Imai
Long-Term Risk in Subjects With White-Coat Hypertension
Hypertension, November 1, 2009; 54(5): e133 - e133.
[Full Text] [PDF]


Home page
HypertensionHome page
P. Verdecchia, F. Angeli, G. Mazzotta, G. Gentile, and G. Reboldi
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring
Hypertension, August 1, 2009; 54(2): 188 - 195.
[Full Text] [PDF]


Home page
HypertensionHome page
V. Pogue, M. Rahman, M. Lipkowitz, R. Toto, E. Miller, M. Faulkner, S. Rostand, L. Hiremath, M. Sika, C. Kendrick, et al.
Disparate Estimates of Hypertension Control From Ambulatory and Clinic Blood Pressure Measurements in Hypertensive Kidney Disease
Hypertension, January 1, 2009; 53(1): 20 - 27.
[Abstract] [Full Text] [PDF]


Home page
Ann Fam MedHome page
M. G. Dawes, G. Bartlett, A. J. Coats, and E. Juszczak
Comparing the Effects of White Coat Hypertension and Sustained Hypertension on Mortality in a UK Primary Care Setting
Ann. Fam. Med, September 1, 2008; 6(5): 390 - 396.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Berend and M. Levi
Is it time to celebrate a century of blood pressure management?
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2558 - 2562.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. W. Hansen, L. Thijs, J. Boggia, Y. Li, M. Kikuya, K. Bjorklund-Bodegard, T. Richart, T. Ohkubo, J. Jeppesen, C. Torp-Pedersen, et al.
Prognostic Value of Ambulatory Heart Rate Revisited in 6928 Subjects From 6 Populations
Hypertension, August 1, 2008; 52(2): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. G. Pickering, N. H. Miller, G. Ogedegbe, L. R. Krakoff, N. T. Artinian, and D. Goff
Call to Action on Use and Reimbursement for Home Blood Pressure Monitoring: A Joint Scientific Statement From the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association
Hypertension, July 1, 2008; 52(1): 10 - 29.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Murakami, A. Hozawa, T. Okamura, H. Ueshima, and the Evidence for Cardiovascular Prevention From Ob
Relation of Blood Pressure and All-Cause Mortality in 180 000 Japanese Participants: Pooled Analysis of 13 Cohort Studies
Hypertension, June 1, 2008; 51(6): 1483 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Dost, C. Klinkert, T. Kapellen, A. Lemmer, A. Naeke, M. Grabert, J. Kreuder, R. W. Holl, and for the DPV Science Initiative
Arterial Hypertension Determined by Ambulatory Blood Pressure Profiles: Contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes
Diabetes Care, April 1, 2008; 31(4): 720 - 725.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
I. Z. Ben-Dov, D. Ben-Ishay, J. Mekler, L. Ben-Arie, and M. Bursztyn
Increased Prevalence of Masked Blood Pressure Elevations in Treated Diabetic Subjects
Arch Intern Med, October 22, 2007; 167(19): 2139 - 2142.
[Full Text] [PDF]


Home page
CJASNHome page
E. S. Ommen, B. Schroppel, J.-Y. Kim, G. Gaspard, E. Akalin, G. de Boccardo, V. Sehgal, M. Lipkowitz, and B. Murphy
Routine Use of Ambulatory Blood Pressure Monitoring in Potential Living Kidney Donors
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 1030 - 1036.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Grassi, G. Seravalle, F. Q. Trevano, R. Dell'Oro, G. Bolla, C. Cuspidi, F. Arenare, and G. Mancia
Neurogenic Abnormalities in Masked Hypertension
Hypertension, September 1, 2007; 50(3): 537 - 542.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Minutolo, S. Borrelli, R. Scigliano, V. Bellizzi, P. Chiodini, B. Cianciaruso, F. Nappi, P. Zamboli, G. Conte, and L. De Nicola
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2217 - 2223.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al.
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Eur. Heart J., June 11, 2007; (2007) ehm236v1.
[Full Text] [PDF]


Home page
CirculationHome page
M. Kikuya, T. W. Hansen, L. Thijs, K. Bjorklund-Bodegard, T. Kuznetsova, T. Ohkubo, T. Richart, C. Torp-Pedersen, L. Lind, H. Ibsen, et al.
Diagnostic Thresholds for Ambulatory Blood Pressure Monitoring Based on 10-Year Cardiovascular Risk
Circulation, April 24, 2007; 115(16): 2145 - 2152.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Kato, T. Horio, M. Tomiyama, K. Kamide, S. Nakamura, F. Yoshihara, H. Nakata, H. Nakahama, and Y. Kawano
Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 911 - 916.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. R. Banegas, J. Segura, J. Sobrino, F. Rodriguez-Artalejo, A. de la Sierra, J. J. de la Cruz, M. Gorostidi, A. Sarria, L. M. Ruilope, and for the Spanish Society of Hypertension Ambulatory
Effectiveness of Blood Pressure Control Outside the Medical Setting
Hypertension, January 1, 2007; 49(1): 62 - 68.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. L. Cuffe, S. C. Howard, A. Algra, C. P. Warlow, and P. M. Rothwell
Medium-Term Variability of Blood Pressure and Potential Underdiagnosis of Hypertension in Patients With Previous Transient Ischemic Attack or Minor Stroke
Stroke, November 1, 2006; 37(11): 2776 - 2783.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Inoue, T. Ohkubo, M. Kikuya, H. Metoki, K. Asayama, T. Obara, H. Hoshi, J. Hashimoto, K. Totsune, H. Satoh, et al.
Predicting Stroke Using 4 Ambulatory Blood Pressure Monitoring-Derived Blood Pressure Indices: The Ohasama Study
Hypertension, November 1, 2006; 48(5): 877 - 882.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. Ohkubo, M. Kikuya, K. Asayama, and Y. Imai
A Proposal for the Cutoff Point of Waist Circumference for the Diagnosis of Metabolic Syndrome in the Japanese Population
Diabetes Care, August 1, 2006; 29(8): 1986 - 1987.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
M. F. O'Rourke and J. B. Seward
Central Arterial Pressure and Arterial Pressure Pulse: New Views Entering the Second Century After Korotkov
Mayo Clin. Proc., August 1, 2006; 81(8): 1057 - 1068.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. Verberk, A. A. Kroon, and P. W. de Leeuw
Masked Hypertension and White-Coat Hypertension Prognosis
J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2127 - 2127.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Ohkubo, M. Kikuya, H. Metoki, K. Asayama, T. Obara, J. Hashimoto, K. Totsune, H. Hoshi, H. Satoh, and Y. Imai
Reply
J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2127 - 2128.
[Full Text] [PDF]


Home page
HypertensionHome page
G. Mancia, R. Facchetti, M. Bombelli, G. Grassi, and R. Sega
Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure
Hypertension, May 1, 2006; 47(5): 846 - 853.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Verdecchia, F. Angeli, and J. A. Staessen
Compared With Whom?: Addressing the Prognostic Value of Ambulatory Blood Pressure Categories
Hypertension, May 1, 2006; 47(5): 820 - 821.
[Full Text] [PDF]


Home page
HypertensionHome page
E. Dolan, L. Thijs, Y. Li, N. Atkins, P. McCormack, S. McClory, E. O'Brien, J. A. Staessen, and A. V. Stanton
Ambulatory Arterial Stiffness Index as a Predictor of Cardiovascular Mortality in the Dublin Outcome Study
Hypertension, March 1, 2006; 47(3): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. R. Krakoff
Cost-Effectiveness of Ambulatory Blood Pressure: A Reanalysis
Hypertension, January 1, 2006; 47(1): 29 - 34.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. W. Hansen, J. Jeppesen, H. Ibsen, E. Dolan, E. T. O'Brien, J. A. Staessen, T. Ohkubo, Y. Imai, R. Sega, R. Facchetti, et al.
Letter Regarding Article by Sega et al, "Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population" * Response
Circulation, September 27, 2005; 112(13): e244 - e246.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. H. Messerli and D. Cotiga
Masked Hypertension and White-Coat Hypertension: Therapeutic Navigation Between Scylla and Charybdis
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 516 - 517.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement